AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like...
AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company's efforts...
Swallowing difficulty may be caused by spinal disease, says study by Hong Kong Chiropractors
A stiff neck or difficulties swallowing could be caused by spinal degeneration, a new study suggests. Researchers found that changes in the spinal curvature...
Orders for NatShield(TM) Sanitizer Disinfectant Spike after Outbreak of Coronavirus
ASX-listed Holista CollTech (ASX:HCT, 'Holista') announced today a strong spike in demand in Malaysia for it all-natural disinfectant spray NatShield™ Sanitizer containing the powerful...
SinoMab Granted the “Most Popular Newly Listed Company” Award
SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the...
IVD Medical wins “Most Valuable Medical and Pharmaceutical Stocks Company” and “Most Popular New...
IVD Medical Holding Limited ("IVD Medical" or the "Group"), a leading distributor of In Vitro Diagnostic ("IVD") products in the PRC, has won the...
Tauriga Sciences, Inc. Approved by Alibaba Group to Operate Global Seller Account
Flagship Product Tauri-Gum(TM) Successfully Listed on Alibaba.com
Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a revenue generating company that operates through the development,...
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological...
Receives Central Government Funding
TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the Company has...
Viva Biotech Was Included as a Constituent Stock of the Hang Seng Hong Kong-Listed...
Viva Biotech Holdings ("Viva Biotech" or the "Company"; stock code: 1873.HK), the world leading operator of a structure-based drug discovery (SBDD) platform, is included...
EuroEyes (1846.HK) Chongqing Clinic Set to Groundbreaking, Officially Enters Southwestern China
EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", stock code: 1846) held the ground-breaking ceremony of its new clinic in Chongqing today, marked...
TOT BIOPHARM Included in the “Suzhou Industrial Park – 2019 Awarded Listed Enterprises”
Granted Subsidy of RMB4 Million
TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the Company,...
Join Asia’s Pharma & Biotech Festival in Singapore
Singapore, Dec 9, 2019 - (ACN Newswire) - The third edition of Phar-East is back once again in Singapore on March 31-April 1, 2020 at Resorts World Convention...
Lee’s Pharm Announces 2019 Third Quarterly Results
The Group's Revenue Up to HK$913 Million
More than 30 approved studies are in progress
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group",...
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate...
SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to...
Interpharma (SET: IP) opens on MAI, targets becoming Top Healthcare and Wellness Brand
Interpharma Plc. (SET: IP), a developer and distributor of Wellness & Anti-Aging and Aesthetic Innovation products (Interpharma) and Companion Animal and Livestock products (Intervetta),...
Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The...
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of...
COPFL announced that its wholly-owned subsidiary-ZKO, has successfully completed a Phase II trial of...
China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO"), has successfully completed a Phase II trial...
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK
SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to...
Cheney Mao – Chairman & CEO, Viva Biotech, China
Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized...
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The...
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces...
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug...
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces...
